CAS: 45506-41-0; Piperidin-2-Ol

该化合物是环状矿,是的酒精衍生物,具有六人环状结构,内含氮原子和与管状环第二碳相连的氢氧基(OH),该化合物一般没有颜色可粉色黄色,具有独特的气味,在水和有机溶剂中溶解,可多种用途.2-Piperidinol以其在合成药物和农用化学品以及生产表面活性剂和其他化学化合物中的中间作用而著称.该化合物的存在有助于其再活动,使其参与各种化学反应,包括氧化和化.此外,该化合物显示出氮原子的温度,可影响其在化学反应和与其他物质相互作用中的行为.在处理该化合物时,应注意安全防范措施,因为如果浸入或吸入,可能会对健康造成危害.

结构式图片

相似化合物

86953-81-3 675-20-7 100707-36-6

上下游产品

Cyclopentanone oxime piperidin-2-one cyclopentanone (2-oxopiperidine-1-yl)chlorobenzene 2,3-dichloro-pyridine

合成工艺路线路线简述

    📜哌啶酮置于sodium Tetrahydroborate,Cobalt(II) Acetate体系中,用 水 作为反应溶剂,化学反应 12.0H,反应生成 2-羟基哌啶
    参考文献:一种2,3-二氯吡啶的合成方法
    标题:一种2,3-二氯吡啶的合成方法
    摘要:本发明提供了一种2,3‑二氯吡啶的合成方法,包括如下步骤:环戊酮与盐酸羟胺反应,以氢氧化钠为缚酸剂,得到化合物a;化合物a在二氯亚砜作用下,发生贝克曼重排反应,得到化合物b;化合物b在醋酸钴催化下,与硼氢化钠反应得到化合物c;化合物c在氯化铵催化下,得到化合物d;化合物d在偶氮二异丁腈作用下,与氯气反应得到化合物e;化合物e和叔丁基次溴酸酯反应,得到2,3‑二氯吡啶.本发明操作步骤简单,所用反应原料廉价易得,总摩尔收率为68.88%,生产出来的2,3‑二氯吡啶纯度为98.0%以上,产品的质量较好,适合于工业化生产.

    海关参考信息

    专利信息


    专利号:US-2013035484-A1
    优先权日:2010-04-15
    标 题:Intermediates useful for the synthesis of pyrrolobenzodiazepines

    专利号:EP-3704130-A1
    优先权日:2017-11-01
    标 题 :Synthesis of boronate ester derivatives and uses thereof

    专利号:EP-0913397-B1
    优先权日:1997-10-22
    标题:A proces for the synthesis of 1-(4-Arylpiperazine-1-y1)-3-(2-oxypyrrolidin/piperidin-1-yl)propanes as therapeutic agents for hypertension, ischemia, cardiovascular and other adrenergic receptors related disorders
    发明人:SINHA NEELIMA; JAIN SANJAY; SAXENA ANIL KUMAR; ANAND NITYA; SAXENA RAM MOHAN; DUBEY MANGAL PRASAD; PATNAIK GYANENDRA KUMAR
    权利人:COUNCIL SCIENT IND RES

    专利号:WO-2024109955-A1
    优先权日:2022-11-22
    标 题:Coordinated metal catalyst, and preparation method therefor and use thereof
    发明人:XUE JINGWEN; LI JINJIN; ZHU WENZHAO; FU JINGQIANG; XIONG GANG
    权利人:PETROCHINA CO LTD
    摘要:Provided in the present invention are a coordination metal catalyst, and a preparation method therefor and the use thereof. The preparation method comprises: mixing a first metal salt with a second metal salt, adding amide-substituted benzene, and leaving the resultant mixture to stand, so as to obtain a coordination metal catalyst, wherein a metal in the first metal salt comprises Co, Pd and Ni; and the anion of the second metal salt comprises a trifluoromethanesulfonate and/or chloride ion. The coordination metal catalyst provided in the present invention has a high catalytic activity and mild reaction conditions, and can be used in reactions for the synthesis of sterically hindered amine and other alcohol amines.

    专利号:US-9102704-B2
    优先权日:2011-10-14
    标 题:Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines
    发明人:HOWARD PHILIP WILSON; TIBERGHIEN ARNAUD
    权利人:SPIROGEN SARL; SPIROGEN SARL
    摘要:A compound of formula I wherein: R 7 is selected from: OR A , where R A is selected from C 1-4 saturated alkyl, optionally substituted by phenyl, which may bear a chloro substituent, pyridyl and furanyl; chloro; NH 2 ; —CH 2 —O—C(â•?O)Me; R 8 is OProt o , where Prot o is a silicon-based oxygen protecting group orthogonal to R c ; R 9 is selected from H, methyl and methoxy; R s is selected from CF 3 , (CF 2 ) 3 CF 3 , CH 3 and (formula 2) and R c is selected from: (i) C(â•?O)—OR C1 , where R C1 is a saturated C 1-4 alkyl group; (ii) —CH 2 —O—C(â•?O)R C2 , where R C2 is methyl or phenyl; (iii) CH 2 —O—Si—(R Si1 )(R Si2 )(R Si3 ), where R Si1 , R Si2 , R Si3 are independently selected from C 1-6 a saturated alkyl group and a phenyl group; and (iv) C(—YR C3 )(—YR C4 ) where each Y is independently O or S, and where R C3 and R C4 are independently a saturated C 1-4 alkyl group, or together form a C 2-3 alylene.

    专利号:EP-2752422-A1
    优先权日:2010-03-31
    标 题 :Stereoselective synthesis of phosphorus containing actives

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s11306-015-0930-4
    摘要:den Ouden H, Pellis L, Rutten GEHM, Geerars-van Vonderen IK, Rubingh CM, van Ommen B, van Erk MJ, Beulens JWJ. Metabolomic biomarkers for personalised glucose lowering drugs treatment in type 2 diabetes. Metabolomics. 2016 Jan 06;12(2):27. doi: 10.1007/s11306-015-0930-4.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知